APO Research
Talk to an analyst

APO RESEARCH · REPORT

Personalized Precision Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Personalized Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 March 2026191 pages

Choose your research edition.

Industry ResearchPersonalized Precision Medicine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Precision Medicine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Personalized Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Precision Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Precision Medicine Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Personalized Precision Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Personalized Precision Medicine include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Personalized Precision Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Personalized Precision Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Personalized Precision Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Personalized Precision Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Personalized Precision Medicine Segment by Company

Agilent Technologies

Biogen

Johnson & Johnson

Boai NKY Pharmaceuticals Ltd.

Novartis

Pfizer

Roche

AstraZeneca

Sanofi

Amgen

Takeda Pharmaceutical

Merck

Eli Lilly

IQVIA

AbbVie

Parexel

Personalized Precision Medicine Segment by Type

Gene Therapy

Personalized Medication

Health Management

Others

Personalized Precision Medicine Segment by Application

Tumors and Cancer

Cardiovascular Diseases

Genetic Disease

Autoimmune Disease

Others

Personalized Precision Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Personalized Precision Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Precision Medicine industry.

Chapter 3: Detailed analysis of Personalized Precision Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Precision Medicinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Personalized Precision Medicine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Gene Therapy Table 3. Key Players of Personalized Medication Table 4. Key Players of Health Management Table 3. Key Players of Others Table 4. Global Personalized Precision Medicine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Tumors and Cancer Table 6. Key Players of Cardiovascular Diseases Table 7. Key Players of Genetic Disease Table 8. Key Players of Autoimmune Disease Table 9. Key Players of Others Table 10. Global Personalized Precision Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Personalized Precision Medicine Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Personalized Precision Medicine Market Share by Region (2021-2026) Table 13. Global Personalized Precision Medicine Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Personalized Precision Medicine Market Share by Region (2027-2032) Table 15. Personalized Precision Medicine Industry Trends Table 16. Personalized Precision Medicine Industry Drivers Table 17. Personalized Precision Medicine Industry Opportunities and Challenges Table 18. Personalized Precision Medicine Industry Restraints Table 19. Global Personalized Precision Medicine Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Personalized Precision Medicine Revenue Market Share by Company (2021-2026) Table 21. Global Personalized Precision Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Personalized Precision Medicine Key Company Head Office and Area Served Table 23. Global Personalized Precision Medicine Company, Product Type & Application Table 24. Global Personalized Precision Medicine Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Personalized Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Personalized Precision Medicine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Personalized Precision Medicine Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Personalized Precision Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Personalized Precision Medicine Revenue Market Share by Type (2027-2032) Table 32. Global Personalized Precision Medicine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Personalized Precision Medicine Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Personalized Precision Medicine Revenue Market Share by Application (2021-2026) Table 36. Global Personalized Precision Medicine Revenue Market Share by Application (2027-2032) Table 37. Agilent Technologies Company Information Table 38. Agilent Technologies Business Overview Table 39. Agilent Technologies Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Agilent Technologies Personalized Precision Medicine Product Portfolio Table 41. Agilent Technologies Recent Development Table 42. Biogen Company Information Table 43. Biogen Business Overview Table 44. Biogen Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Biogen Personalized Precision Medicine Product Portfolio Table 46. Biogen Recent Development Table 47. Johnson & Johnson Company Information Table 48. Johnson & Johnson Business Overview Table 49. Johnson & Johnson Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Johnson & Johnson Personalized Precision Medicine Product Portfolio Table 51. Johnson & Johnson Recent Development Table 52. Boai NKY Pharmaceuticals Ltd. Company Information Table 53. Boai NKY Pharmaceuticals Ltd. Business Overview Table 54. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio Table 56. Boai NKY Pharmaceuticals Ltd. Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis Personalized Precision Medicine Product Portfolio Table 61. Novartis Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pfizer Personalized Precision Medicine Product Portfolio Table 66. Pfizer Recent Development Table 67. Roche Company Information Table 68. Roche Business Overview Table 69. Roche Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Roche Personalized Precision Medicine Product Portfolio Table 71. Roche Recent Development Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. AstraZeneca Personalized Precision Medicine Product Portfolio Table 76. AstraZeneca Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sanofi Personalized Precision Medicine Product Portfolio Table 81. Sanofi Recent Development Table 82. Amgen Company Information Table 83. Amgen Business Overview Table 84. Amgen Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Amgen Personalized Precision Medicine Product Portfolio Table 86. Amgen Recent Development Table 87. Takeda Pharmaceutical Company Information Table 88. Takeda Pharmaceutical Business Overview Table 89. Takeda Pharmaceutical Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio Table 91. Takeda Pharmaceutical Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Merck Personalized Precision Medicine Product Portfolio Table 96. Merck Recent Development Table 97. Eli Lilly Company Information Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Eli Lilly Personalized Precision Medicine Product Portfolio Table 101. Eli Lilly Recent Development Table 102. IQVIA Company Information Table 103. IQVIA Business Overview Table 104. IQVIA Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. IQVIA Personalized Precision Medicine Product Portfolio Table 106. IQVIA Recent Development Table 107. AbbVie Company Information Table 108. AbbVie Business Overview Table 109. AbbVie Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. AbbVie Personalized Precision Medicine Product Portfolio Table 111. AbbVie Recent Development Table 112. Parexel Company Information Table 113. Parexel Business Overview Table 114. Parexel Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Parexel Personalized Precision Medicine Product Portfolio Table 116. Parexel Recent Development Table 117. North America Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 118. North America Personalized Precision Medicine Market Size by Type (2027-2032) & (US$ Million) Table 119. North America Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 120. North America Personalized Precision Medicine Market Size by Application (2027-2032) & (US$ Million) Table 121. North America Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Personalized Precision Medicine Market Size by Country (2021-2026) Table 123. North America Personalized Precision Medicine Market Size by Country (2027-2032) Table 124. Europe Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 125. Europe Personalized Precision Medicine Market Size by Type (2027-2032) & (US$ Million) Table 126. Europe Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 127. Europe Personalized Precision Medicine Market Size by Application (2027-2032) & (US$ Million) Table 128. Europe Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Personalized Precision Medicine Market Size by Country (2021-2026) Table 130. Europe Personalized Precision Medicine Market Size by Country (2027-2032) Table 131. China Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 132. China Personalized Precision Medicine Market Size by Type (2027-2032) & (US$ Million) Table 133. China Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 134. China Personalized Precision Medicine Market Size by Application (2027-2032) & (US$ Million) Table 135. Asia Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 136. Asia Personalized Precision Medicine Market Size by Type (2027-2032) & (US$ Million) Table 137. Asia Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 138. Asia Personalized Precision Medicine Market Size by Application (2027-2032) & (US$ Million) Table 139. Asia Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Personalized Precision Medicine Market Size by Country (2021-2026) Table 141. Asia Personalized Precision Medicine Market Size by Country (2027-2032) Table 142. South America, Middle East & Africa Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Personalized Precision Medicine Market Size by Type (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa Personalized Precision Medicine Market Size by Application (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. South America, Middle East & Africa Personalized Precision Medicine Market Size by Country (2021-2026) Table 148. South America, Middle East & Africa Personalized Precision Medicine Market Size by Country (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Personalized Precision Medicine Product Image Figure 2. Global Personalized Precision Medicine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Personalized Precision Medicine Market Share by Type: 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Personalized Medication Image Figure 6. Health Management Image Figure 7. Others Image Figure 8. Global Personalized Precision Medicine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Personalized Precision Medicine Market Share by Application: 2025 VS 2032 Figure 10. Tumors and Cancer Image Figure 11. Cardiovascular Diseases Image Figure 12. Genetic Disease Image Figure 13. Autoimmune Disease Image Figure 14. Others Image Figure 15. Global Personalized Precision Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 17. Global Personalized Precision Medicine Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Personalized Precision Medicine Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Personalized Precision Medicine Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Personalized Precision Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Personalized Precision Medicine Revenue Market Share by Type (2021-2032) Figure 24. Global Personalized Precision Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Personalized Precision Medicine Revenue Market Share by Application (2021-2032) Figure 26. North America Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 27. North America Personalized Precision Medicine Market Share by Type (2021-2032) Figure 28. North America Personalized Precision Medicine Market Share by Application (2021-2032) Figure 29. North America Personalized Precision Medicine Market Share by Country (2021-2032) Figure 30. United States Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 31. Canada Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 33. Europe Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 34. Europe Personalized Precision Medicine Market Share by Type (2021-2032) Figure 35. Europe Personalized Precision Medicine Market Share by Application (2021-2032) Figure 36. Europe Personalized Precision Medicine Market Share by Country (2021-2032) Figure 37. Germany Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 38. France Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 40. Italy Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 41. Russia Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 43. China Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 44. China Personalized Precision Medicine Market Share by Type (2021-2032) Figure 45. China Personalized Precision Medicine Market Share by Application (2021-2032) Figure 46. Asia Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 47. Asia Personalized Precision Medicine Market Share by Type (2021-2032) Figure 48. Asia Personalized Precision Medicine Market Share by Application (2021-2032) Figure 49. Asia Personalized Precision Medicine Market Share by Country (2021-2032) Figure 50. Japan Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 54. India Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 55. Australia Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Personalized Precision Medicine Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Personalized Precision Medicine Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Personalized Precision Medicine Market Share by Country (2021-2032) Figure 60. Brazil Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 65. UAE Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 67. Chile Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Personalized Medication
  • Health Management
  • Others
Applications
  • Tumors and Cancer
  • Cardiovascular Diseases
  • Genetic Disease
  • Autoimmune Disease
  • Others
Companies covered
  • Agilent Technologies
  • Biogen
  • Johnson & Johnson
  • Boai NKY Pharmaceuticals Ltd.
  • Novartis
  • Pfizer
  • Roche
  • AstraZeneca
  • Sanofi
  • Amgen
  • Takeda Pharmaceutical
  • Merck
  • Eli Lilly
  • IQVIA
  • AbbVie
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Personalized Precision Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Personalized Medication
  6. 1.2.4 Health Management
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Personalized Precision Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Tumors and Cancer
  11. 1.3.3 Cardiovascular Diseases
  12. 1.3.4 Genetic Disease
  13. 1.3.5 Autoimmune Disease
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Personalized Precision Medicine Growth Trends by Region
  17. 1.5.1 Global Personalized Precision Medicine Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Personalized Precision Medicine Market Size by Region (2021-2026)
  19. 1.5.3 Personalized Precision Medicine Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Personalized Precision Medicine Market Dynamics
  1. 2.1 Personalized Precision Medicine Industry Trends
  2. 2.2 Personalized Precision Medicine Industry Drivers
  3. 2.3 Personalized Precision Medicine Industry Opportunities and Challenges
  4. 2.4 Personalized Precision Medicine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Personalized Precision Medicine Revenue by Company (2021-2026)
  2. 3.2 Global Personalized Precision Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Personalized Precision Medicine Key Company Head office and Area Served
  4. 3.4 Global Personalized Precision Medicine Company, Product Type & Application
  5. 3.5 Global Personalized Precision Medicine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Personalized Precision Medicine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Personalized Precision Medicine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Personalized Precision Medicine Tier 1, Tier 2, and Tier 3
4 Personalized Precision Medicine Market by Type
  1. 4.1 Global Personalized Precision Medicine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Personalized Precision Medicine Market Size by Type (2021-2032)
  3. 4.3 Global Personalized Precision Medicine Market Size Share by Type (2021-2032)
5 Personalized Precision Medicine Market by Application
  1. 5.1 Global Personalized Precision Medicine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Personalized Precision Medicine Market Size by Application (2021-2032)
  3. 5.3 Global Personalized Precision Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Agilent Technologies
  2. 6.1.1 Agilent Technologies Company Information
  3. 6.1.2 Agilent Technologies Business Overview
  4. 6.1.3 Agilent Technologies Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Agilent Technologies Personalized Precision Medicine Product Portfolio
  6. 6.1.5 Agilent Technologies Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biogen Personalized Precision Medicine Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson & Johnson Personalized Precision Medicine Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Boai NKY Pharmaceuticals Ltd.
  20. 6.4.1 Boai NKY Pharmaceuticals Ltd. Company Information
  21. 6.4.2 Boai NKY Pharmaceuticals Ltd. Business Overview
  22. 6.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio
  24. 6.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Personalized Precision Medicine Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer Personalized Precision Medicine Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Roche Personalized Precision Medicine Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AstraZeneca Personalized Precision Medicine Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sanofi Personalized Precision Medicine Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Amgen
  56. 6.10.1 Amgen Company Information
  57. 6.10.2 Amgen Business Overview
  58. 6.10.3 Amgen Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Amgen Personalized Precision Medicine Product Portfolio
  60. 6.10.5 Amgen Recent Developments
  61. 6.11 Takeda Pharmaceutical
  62. 6.11.1 Takeda Pharmaceutical Company Information
  63. 6.11.2 Takeda Pharmaceutical Business Overview
  64. 6.11.3 Takeda Pharmaceutical Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio
  66. 6.11.5 Takeda Pharmaceutical Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Merck Personalized Precision Medicine Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Eli Lilly
  74. 6.13.1 Eli Lilly Company Information
  75. 6.13.2 Eli Lilly Business Overview
  76. 6.13.3 Eli Lilly Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Eli Lilly Personalized Precision Medicine Product Portfolio
  78. 6.13.5 Eli Lilly Recent Developments
  79. 6.14 IQVIA
  80. 6.14.1 IQVIA Company Information
  81. 6.14.2 IQVIA Business Overview
  82. 6.14.3 IQVIA Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 IQVIA Personalized Precision Medicine Product Portfolio
  84. 6.14.5 IQVIA Recent Developments
  85. 6.15 AbbVie
  86. 6.15.1 AbbVie Company Information
  87. 6.15.2 AbbVie Business Overview
  88. 6.15.3 AbbVie Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 AbbVie Personalized Precision Medicine Product Portfolio
  90. 6.15.5 AbbVie Recent Developments
  91. 6.16 Parexel
  92. 6.16.1 Parexel Company Information
  93. 6.16.2 Parexel Business Overview
  94. 6.16.3 Parexel Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Parexel Personalized Precision Medicine Product Portfolio
  96. 6.16.5 Parexel Recent Developments
7 North America
  1. 7.1 North America Personalized Precision Medicine Market Size (2021-2032)
  2. 7.2 North America Personalized Precision Medicine Market Size by Type
  3. 7.2.1 North America Personalized Precision Medicine Market Size by Type (2021-2026)
  4. 7.2.2 North America Personalized Precision Medicine Market Size by Type (2027-2032)
  5. 7.2.3 North America Personalized Precision Medicine Market Share by Type (2021-2032)
  6. 7.3 North America Personalized Precision Medicine Market Size by Application
  7. 7.3.1 North America Personalized Precision Medicine Market Size by Application (2021-2026)
  8. 7.3.2 North America Personalized Precision Medicine Market Size by Application (2027-2032)
  9. 7.3.3 North America Personalized Precision Medicine Market Share by Application (2021-2032)
  10. 7.4 North America Personalized Precision Medicine Market Size by Country
  11. 7.4.1 North America Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Personalized Precision Medicine Market Size by Country (2021-2026)
  13. 7.4.3 North America Personalized Precision Medicine Market Size by Country (2027-2032)
  14. 7.4.4 North America Personalized Precision Medicine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Personalized Precision Medicine Market Size (2021-2032)
  2. 8.2 Europe Personalized Precision Medicine Market Size by Type
  3. 8.2.1 Europe Personalized Precision Medicine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Personalized Precision Medicine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Personalized Precision Medicine Market Share by Type (2021-2032)
  6. 8.3 Europe Personalized Precision Medicine Market Size by Application
  7. 8.3.1 Europe Personalized Precision Medicine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Personalized Precision Medicine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Personalized Precision Medicine Market Share by Application (2021-2032)
  10. 8.4 Europe Personalized Precision Medicine Market Size by Country
  11. 8.4.1 Europe Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Personalized Precision Medicine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Personalized Precision Medicine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Personalized Precision Medicine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Personalized Precision Medicine Market Size (2021-2032)
  2. 9.2 China Personalized Precision Medicine Market Size by Type
  3. 9.2.1 China Personalized Precision Medicine Market Size by Type (2021-2026)
  4. 9.2.2 China Personalized Precision Medicine Market Size by Type (2027-2032)
  5. 9.2.3 China Personalized Precision Medicine Market Share by Type (2021-2032)
  6. 9.3 China Personalized Precision Medicine Market Size by Application
  7. 9.3.1 China Personalized Precision Medicine Market Size by Application (2021-2026)
  8. 9.3.2 China Personalized Precision Medicine Market Size by Application (2027-2032)
  9. 9.3.3 China Personalized Precision Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Personalized Precision Medicine Market Size (2021-2032)
  2. 10.2 Asia Personalized Precision Medicine Market Size by Type
  3. 10.2.1 Asia Personalized Precision Medicine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Personalized Precision Medicine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Personalized Precision Medicine Market Share by Type (2021-2032)
  6. 10.3 Asia Personalized Precision Medicine Market Size by Application
  7. 10.3.1 Asia Personalized Precision Medicine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Personalized Precision Medicine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Personalized Precision Medicine Market Share by Application (2021-2032)
  10. 10.4 Asia Personalized Precision Medicine Market Size by Country
  11. 10.4.1 Asia Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Personalized Precision Medicine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Personalized Precision Medicine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Personalized Precision Medicine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Personalized Precision Medicine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Personalized Precision Medicine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Personalized Precision Medicine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Personalized Precision Medicine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Personalized Precision Medicine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Personalized Precision Medicine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Personalized Precision Medicine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Personalized Precision Medicine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Personalized Precision Medicine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Personalized Precision Medicine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Personalized Precision Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Personalized Precision Medicine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Personalized Precision Medicine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Personalized Precision Medicine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst